J. J. Volpe, Neurology of the newborn, 2008.

S. N. Rakhade and F. E. Jensen, Epileptogenesis in the immature brain: emerging mechanisms, Nat Rev Neurol, vol.5, pp.380-91, 2009.

R. M. Sanchez and F. E. Jensen, Maturation aspects of epilepsy mechanisms and consequences for the immature brain, Epilepsia, vol.42, issue.5, pp.577-85, 2001.

C. Vasudevan and M. Levene, Epidemiolgy and aetiology of neonatal seizures, Semin Fetal Neonatal Med, vol.18, issue.4, pp.185-91, 2013.

M. J. Lanska, D. J. Lanska, and R. J. Baumann, A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology, vol.45, pp.724-756, 1995.

G. M. Ronen, S. Penney, and W. Andrews, The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study, J Pediatr, vol.134, pp.71-76, 1999.

R. M. Saliba, J. F. Annegers, and D. K. Waller, Am J Epidemiol, vol.150, pp.763-772, 1992.

A. R. Hart, E. L. Pilling, and J. Alix, Neonatal seizures-part 2 : aetiology of acute symptomatic seizures, treatments and the neonatal epilepsy syndromes, Arch Dis Child Educ Pract Ed, vol.100, pp.226-258, 2015.

F. Pisani, C. Facini, and E. Pavlidis, Epilepsy after neonatal seizures : literature review, Eur J Paediatr Neurol, vol.19, issue.1, pp.6-14, 2015.

A. Soltirovska-salamon, D. Neubauer, and A. Petrovcic, Risk factors and scoring system as a prognostic tool epilepsy after neonatal seizures, Pediatr Neurol, vol.50, issue.1, pp.77-84, 2014.

, World Health Organization. Guidelines on neonatal seizures. Geneva: WHO, 2011.

H. C. Glass, J. Kan, S. L. Bonifacio, and D. M. Ferriero, Neonatal seizures: treatment practices among term and preterm, Pediatr Neurol, vol.46, pp.111-116, 2012.

R. Wickstrom, B. Hallberg, and M. Bartocci, Differing attitudes toward phenobarbital use in the neonatal period among neonatologists and child neurologists in Sweden, Eur J Paediatr Neurol, vol.17, pp.55-63, 2013.

P. Bittigau, M. Sifringer, and K. Genz, Antiepileptic drugs and apoptotic neurodegeneration in the developing brain, Proc Natl Acad Sci U S A, vol.99, pp.15089-94, 2002.

J. R. Farwell and J. Y. Lee, Phenobarbital for febrile seizures effects on intelligence and on seizure recurrence, N Engl J Med, vol.322, pp.364-373, 1990.

M. R. Koenigsberger, F. J. Caballar-gonzaga, and T. Dierkes, Neonatal seizures : the beginning and interruption of the treatment, Rev Neurol, vol.25, issue.141, pp.706-714, 1997.

P. Scarpa, R. Chierici, and L. Tamisari, Criteria for discontinuing neonatal seizure therapy: a long-term appraisal, Brain and Development, vol.5, pp.541-549, 1983.

H. C. Glass, R. A. Shellhaas, and C. J. Wusthoff, Contemporary profile of seizures in neonates : a prospective cohort study, J Pediatr, vol.174, pp.98-103, 2016.

D. M. Murray, G. B. Boylan, A. I. Ryan, C. A. Murphy, B. P. Connolly et al., Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures, Arch Dis Child Fetal Neonatal Ed, vol.93, pp.187-91, 2008.

M. Mastrangelo, A. Van-lierde, and M. Bray, Epilepstic seizures, epilepsy and epieptic syndromes in newborns : a nosological approach of 94 new cases by the 2001 proposed diagnostic scheme for people with epileptic seizures and epilepsy, Seizure, vol.14, issue.5, pp.304-315, 2005.

A. I. Bartha, J. Shen, and K. H. Kat, Neonatal seizures : Muticenter variability in current treatment Pratices, Pediatr Neurol, vol.37, pp.85-90, 2007.

E. Baudou, J. Benevent, J. L. Montastruc, and G. Touati, Hachon LeCamus C. adverse effects of treatment with Valproic acid during the neonatal period, Neuropediatrics, 2018.

B. Singh, P. Singh, A. Hifzi, and I. , Treatment of neonatal seizures with carbamazepine, J Child Neurol, vol.11, pp.378-82, 1996.

T. Hoppen, C. Erichelger, and P. Bartmann, Carbamazepine in phenobarbital-non responders: experience with ten preterm infants, Eur J Pediatr, vol.160, pp.444-451, 2001.

A. Weinstock, M. Ruiz, D. Gerard, N. Toublanc, A. Stockis et al., Prospective open-label, single-arm, multicenter, safety, tolerability, and pharmacokinetic studies of intravenous levetiracetam in children with epilepsy, J Child Neurol, vol.28, issue.11, pp.1423-1432, 2013.

T. A. Glauser, R. Ayala, and R. D. Elterman, Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures, Neurology, vol.66, pp.1654-60, 2006.

O. Khan, E. Chang, C. Cipriani, C. Wright, E. Crisp et al., Use of intravenous levetiracetam for management of acute seizures in neonates, Pediatr Neurol, vol.44, pp.265-274, 2011.

A. Rakshasbhuvankar, S. Rao, R. Kohan, K. Simmer, and L. Nagarajan, Intravenous levetiracetam for treatment of neonatal seizures, J Clin Neurosci, vol.20, pp.1165-1172, 2013.

N. S. Abend, A. M. Gutierrez-colina, H. M. Monk, D. J. Dlugos, and R. R. Clancy, Levetiracetam for treatment of neonatal seizures, J Child Neurol, vol.26, pp.465-70, 2011.

G. Ramantani, C. Ikonomidou, and B. Walter, Levetiracetam: safety and efficacy in neonatal seizures, Eur J Paediatr Neurol, vol.15, issue.1, pp.1-7, 2011.

A. Steinberg, R. Shalev, and N. Amir, Valproic acid in neonatal status convulsivus, Brain Dev, vol.8, issue.3, pp.278-820, 1986.

I. Alfonso, L. A. Alvarez, C. Dunoyer, K. Yelin, and O. Papazian, Intravenous valproate dosing in neonates, J Child Neurol, vol.15, issue.12, pp.827-836, 2000.

P. Gal, K. S. Oles, J. T. Gilman, and R. Weaver, Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures, Neurology, vol.38, issue.3, pp.467-71, 1988.

J. M. Irvine-meek, K. W. Hall, and N. H. Otten, Pharmacokinetic study of valproic acid in a neonate, Pediatr Pharmacol, vol.2, issue.4, pp.317-338, 1982.

D. Graham, Neuropathology of vigabatrin, Br J Clin Pharmac, vol.27, pp.43-48, 1989.

W. H. Butler, G. P. Ford, and J. W. Newberne, A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Listerhooded rats, Toxicol Pathol, vol.15, pp.143-151, 1987.

T. Eke, J. F. Talbot, and M. C. Lawden, Severe persistent visual field constriction associated with vigabatrin, BMJ, vol.314, p.180, 1997.

M. J. Maguire, K. Hemming, and J. M. Wild, Prevalence of visual fiels loss following exposure to vigabatrin therapy: a systematic review, Epilepsia, vol.51, issue.12, pp.2123-2154, 2010.

I. Ingster-moati and C. Orssaud, Protocole de surveillance ophtalmologique des patients traites par antipaludeens de synthese ou par vigabatrin au long cours, Journal francais d'ophtalmologie, vol.32, pp.83-88, 2009.

P. S. Baxter, D. Gardner-medwin, and D. D. Barwick, Vigabatrin monotherapy in resistant neonatal seizures, Seizure, vol.4, pp.57-66, 1995.

F. Vauzelle-kervroidan, R. E. Pons, and G. , Pharmacokinetics of the inidvidual enantiomers of vigabatrin in neonates with uncontrolled seizures, Br J Clin Pharmacol, vol.42, pp.779-81, 1996.

T. Pisano, A. L. Numis, and S. B. Heavin, Early effective treatment of KCNQ2 encephalopathy, Epilepsia, vol.56, issue.5, pp.685-91, 2015.

T. T. Sands, M. Balestri, and G. Bellini, Rapid and safe response to low-dose carbamazepine in neonatal epilepsy, Epilepsia, vol.57, issue.12, pp.2019-2049, 2016.

R. Dilena, P. Striano, and E. Gennaro, Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy. Brain and Development, vol.39, pp.345-353, 2017.

O. Baud, S. Auvin, and E. Saliba, Prise en charge thérapeutique des convulsions associées à l'accident vasculaire cérébral du nouveau-né et perspectives de neuroprotection à la phase aiguë, Arch Pediatr, vol.24, issue.9, pp.9-46, 2017.